Fate Therapeutics, Inc. - Common Stock (NQ:FATE)
1.095
+0.045
(+4.29%)
Streaming Delayed Price
Updated: 2:08 PM EST, Dec 19, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 865,029 |
| Open | 1.050 |
| Bid (Size) | 1.090 (2,500) |
| Ask (Size) | 1.100 (8,700) |
| Prev. Close | 1.050 |
| Today's Range | 1.030 - 1.120 |
| 52wk Range | 0.6611 - 1.990 |
| Shares Outstanding | 98,384,456 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 30, 2025
Fate Therapeutics to Present at Upcoming Investor Conferences
August 25, 2025
Gapping stocks in Monday's session ↗
April 14, 2025
Frequently Asked Questions
Is Fate Therapeutics, Inc. - Common Stock publicly traded?
Yes, Fate Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Fate Therapeutics, Inc. - Common Stock trade on?
Fate Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fate Therapeutics, Inc. - Common Stock?
The ticker symbol for Fate Therapeutics, Inc. - Common Stock is FATE on the Nasdaq Stock Market
What is the current price of Fate Therapeutics, Inc. - Common Stock?
The current price of Fate Therapeutics, Inc. - Common Stock is 1.095
When was Fate Therapeutics, Inc. - Common Stock last traded?
The last trade of Fate Therapeutics, Inc. - Common Stock was at 12/19/25 02:08 PM ET
What is the market capitalization of Fate Therapeutics, Inc. - Common Stock?
The market capitalization of Fate Therapeutics, Inc. - Common Stock is 107.73M
How many shares of Fate Therapeutics, Inc. - Common Stock are outstanding?
Fate Therapeutics, Inc. - Common Stock has 108M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.